Akebia Therapeutics, Inc.
← Back to AKBA Overview

Akebia Therapeutics, Inc. (AKBA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-8.72

Financial Fundamentals

AKBA • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2012-12-31-91.20
2013-03-31-108.93
2013-06-30-23.90
2013-09-30-17.95
2013-12-31-16.71
2014-03-31-7.51
2014-06-30-17.92
2014-09-30-11.65
2014-12-31-5.57
2015-03-31-5.20
2015-06-30-6.41
2015-09-30-3.57
2015-12-31-6.00
2016-03-31-3.22
2016-06-30-1.98
2016-09-30-2.36
2016-12-31-2.63
2017-03-31-2.00
2017-06-30-6.82
2017-09-30-9.98
2017-12-3114.35
2018-03-31-4.95
2018-06-30-4.17
2018-09-30-4.66
2018-12-31-1.83
2019-03-31-3.25
2019-06-30-2.35
2019-09-30-2.13
2019-12-31-2.00
2020-03-31-4.01
2020-06-30-2.64
2020-09-30-1.50
2020-12-31-1.17
2021-03-31-1.87
2021-06-30-1.84
2021-09-30-2.10
2021-12-31-1.41
2022-03-31-0.52
2022-06-300.55
2022-09-30-0.27
2022-12-31-3.51
2023-03-31-0.96
2023-06-30-3.83
2023-09-30-3.70
2023-12-3195.88
2024-03-31-4.64
2024-06-30-6.07
2024-09-30-3.46
2024-12-31-4.56
2025-03-3118.49
2025-06-30967.35
2025-09-30334.66
2025-12-31-8.72

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.